Value of SATB2 Immunostaining in the Distinction between Small Intestinal and Colorectal Adenocarcinomas

被引:0
|
作者
Kim, C. J.
Baruch-Oren, T.
Lin, F.
Fan, X.
Yang, X. J.
Wang, H. L.
机构
[1] Univ Calif Los Angeles, Los Angeles, CA USA
[2] Geisinger Med Ctr, Danville, PA 17822 USA
[3] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[4] Northwestern Univ, Chicago, IL 60611 USA
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
749
引用
收藏
页码:184A / 184A
页数:1
相关论文
共 50 条
  • [21] Small Bowel Adenocarcinomas Featuring Special AT-Rich Sequence-Binding Protein 2 (SATB2) Expression and a Colorectal Cancer-Like Immunophenotype: A Potential Diagnostic Pitfall
    Neri, Giuseppe
    Arpa, Giovanni
    Guerini, Camilla
    Grillo, Federica
    Lenti, Marco Vincenzo
    Giuffrida, Paolo
    Furlan, Daniela
    Sessa, Fausto
    Quaquarini, Erica
    Viglio, Alessandra
    Ubezio, Cristina
    Pasini, Alessandra
    Ferrero, Stefano
    Sampietro, Gianluca
    Ardizzone, Sandro
    Latella, Giovanni
    Mescoli, Claudia
    Rugge, Massimo
    Zingone, Fabiana
    Barresi, Valeria
    Ciccocioppo, Rachele
    Pedrazzoli, Paolo
    Corazza, Gino Roberto
    Luinetti, Ombretta
    Solcia, Enrico
    Paulli, Marco
    Di Sabatino, Antonio
    Vanoli, Alessandro
    CANCERS, 2020, 12 (11) : 1 - 14
  • [22] Immunohistochemical Expression Profile of SATB2 in Colorectal Adenocarcinoma and Association with Clinicopathological Parameters
    Suvaitha, M.
    Anand, C. D.
    John, Jaison Jacob
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2023, 17 (03) : EC31 - EC36
  • [23] SATB2 as an Immunohistochemical Marker for Colorectal Adenocarcinoma A Concise Review of Benefits and Pitfalls
    Berg, Kyra B.
    Schaeffer, David F.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2017, 141 (10) : 1428 - 1433
  • [24] SATB2 is a promising biomarker for identifying colorectal origin in liver metastatic adenocarcinoma
    Cai, M. -Y.
    Zhang, Y. -J.
    Chen, J. -W.
    Zhang, H. -Z.
    Yun, J. -P.
    Xie, D.
    VIRCHOWS ARCHIV, 2016, 469 : S161 - S161
  • [25] Use of SATB2 and CDX2 Immunohistochemistry to Characterize and Diagnose Colorectal Cancer
    Kato, Shunsuke
    Koshino, Akira
    Lasota, Jerzy
    Komura, Masayuki
    Wang, Chengbo
    Ebi, Masahide
    Ogasawara, Naotaka
    Kojima, Kazuhisa
    Tsuzuki, Toyonori
    Kasai, Kenji
    Takahashi, Satoru
    Miettinen, Markku
    Kasugai, Kunio
    Inaguma, Shingo
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2024, 32 (08) : 362 - 370
  • [26] The Role of SATB2 as a Diagnostic Marker of Sinonasal Intestinal-type Adenocarcinoma
    Skalova, Alena
    Sar, Aylin
    Laco, Jan
    Metelkova, Alena
    Miesbauerova, Marketa
    Steiner, Petr
    Svajdler, Marian
    Michal, Michal
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2018, 26 (02) : 140 - 146
  • [27] miR-449a inhibits colorectal cancer progression by targeting SATB2
    Sun, Xiaohua
    Liu, Sanhong
    Chen, Pengfei
    Fu, Da
    Hou, Yingyong
    Hu, Jin
    Liu, Zhi
    Jiang, Yuhang
    Cao, Xinwei
    Cheng, Chunyan
    Chen, Xi
    Tao, Yu
    Li, Cuifeng
    Hu, Yiming
    Liu, Zhanjie
    Zhan, Yu
    Mao, Jie
    Wang, Qi
    Ma, Yushui
    Cong, Xianling
    Sun, Ran
    Shi, Yufang
    Wang, Mingliang
    Zhang, Xiaoren
    ONCOTARGET, 2017, 8 (60) : 100975 - 100988
  • [28] Lung Adenocarcinoma with Mucin: Role of SATB2 in Assessing for Mucinous Colorectal Metastasis
    De Michele, Simona
    Remotti, Helen
    Del Portillo, Armando
    Szabolcs, Matthias
    Saqi, Anjali
    LABORATORY INVESTIGATION, 2019, 99
  • [29] Lung Adenocarcinoma with Mucin: Role of SATB2 in Assessing for Mucinous Colorectal Metastasis
    De Michele, Simona
    Remotti, Helen
    Del Portillo, Armando
    Szabolcs, Matthias
    Saqi, Anjali
    MODERN PATHOLOGY, 2019, 32
  • [30] Impact of Neoadjuvant Chemotherapy on SATB2 Expression in Colorectal Carcinomas: SATB2 Positivity is Preserved in Most Cases, but Down-Expressed in Effective Cases of Chemotherapy
    Asahina, Yuichi
    Hashimoto, Hirotsugu
    Aihara, Makoto
    Noie, Tamaki
    Morikawa, Teppei
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2023, 31 (01) : 46 - 55